No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ANEB Anebulo Pharmaceuticals
- 0.990
- -0.120-10.81%
Close Dec 20 16:00 ET
- 0.990
- 0.0000.00%
Post 20:01 ET
25.67MMarket Cap-3.30P/E (TTM)
1.274High0.800Low88.12KVolume1.170Open1.110Pre Close83.54KTurnover2.25%Turnover RatioLossP/E (Static)25.93MShares3.30052wk High13.56P/B3.87MFloat Cap0.80052wk Low--Dividend TTM3.91MShs Float9.330Historical High--Div YieldTTM42.73%Amplitude0.800Historical Low0.948Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Anebulo Pharmaceuticals | 10-Q: Q1 2025 Earnings Report
Anebulo Pharmaceuticals Q1 EPS $(0.08) Up From $(0.10) YoY
Anebulo Pharmaceuticals | 8-K: Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates
Benchmark Co. Maintains Anebulo Pharmaceuticals(ANEB.US) With Buy Rating, Maintains Target Price $8
Benchmark Reiterates Speculative Buy on Anebulo Pharmaceuticals, Maintains $8 Price Target
Anebulo Pharmaceuticals Analyst Ratings
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock the Full List